HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic.

AbstractBACKGROUND:
The aim of this study is to confirm the diagnostic performance of the Chylomicron to very low-density lipoproteins triglycerides (CM/VLDL-TG) ratio, the triglycerides to cholesterol ratio (TG/TC) and a dichotomic rule including the tryglycerides to apolipoprotein B (TG/APOB) ratio for the presence of Type I hyperlipoproteinemia (HPLI) in patients with severe hypertriglyceridemia (sHTG) that were at high risk for familial chylomicronemia syndrome (FCS).
METHODS:
Two cohorts (derivation and validation) of patients with sHTG were included in the study. Anthropometric, clinical, biochemical and genetic data were obtained. The CM/VLDL-TG, TG/TC and TG/APOB ratios were calculated. Finally, a diagnostic performance study was developed to establish sensitivity, specificity and cut-offs by a ROC curve analysis in the derivation cohort as well as agreement and predictive values in the validation cohort.
RESULTS:
Patients with FCS in both cohorts showed an earlier presence in pancreatitis, greater number of acute pancreatitis episodes and lower BMI. FCS patients also showed higher ratios of CM/VLDL-TG, TG/TC and TG/APOB ratios, whereas their HDL-C, LDL-C and APOB levels were lower than in non-FCS patients. Sensitivity and agreement were low for both the TG/TC and TG/APOB ratios, although predictive values were good. The CM/VLDL-TG ratio showed greatest sensitivity, specificity, agreement and predictive values for cut-off of 3.8 and 4.5.
CONCLUSIONS:
Our results suggest that in subjects at high risk of FCS a total serum TG/TC ratio or TG/APOB ratio are feasible to initially screen for HLPI; however, a CM/VLDL-TG ratio ≥4.5 is a better diagnostic criterion for HPLI.
AuthorsJosé Rioja, María-José Ariza, Natalia García-Casares, Inmaculada Coca-Prieto, Teresa Arrobas, Ovidio Muñiz-Grijalvo, Alipio Mangas, Daiana Ibarretxe, Miguel Ángel Sánchez-Chaparro, Pedro Valdivielso
JournalEuropean journal of clinical investigation (Eur J Clin Invest) Vol. 50 Issue 12 Pg. e13345 (Dec 2020) ISSN: 1365-2362 [Electronic] England
PMID32649781 (Publication Type: Journal Article)
Copyright© 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Chemical References
  • Apolipoproteins B
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Chylomicrons
  • Lipoproteins, VLDL
  • Triglycerides
  • very low density lipoprotein triglyceride
  • Cholesterol
Topics
  • Adolescent
  • Adult
  • Apolipoproteins B (blood)
  • Body Mass Index
  • Cholesterol (blood)
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Chylomicrons (blood)
  • Female
  • Humans
  • Hyperlipoproteinemia Type I (blood, diagnosis, epidemiology)
  • Hypertriglyceridemia (blood)
  • Lipoproteins, VLDL (blood)
  • Male
  • Middle Aged
  • Pancreatitis (epidemiology)
  • ROC Curve
  • Recurrence
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Triglycerides (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: